Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 498
interventional 422
Observational 70
Registry 6

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug|placebo 114
Drug 62
Other 57
Behavioral 53
Dietary Supplement|placebo 35
Dietary Supplement 29
Device 15
Procedure 12
Other|placebo 7
Drug|Procedure 4
placebo|Procedure 4
Dietary Supplement|Other 3
Drug|Other 3
Drug|Other|placebo 3
Behavioral|Dietary Supplement 2
Behavioral|Drug 2
Behavioral|Other 2
Behavioral|placebo 2
Biological 2
Biological|placebo 2
Device|Drug 2
Device|placebo 2
placebo 2
Behavioral|Drug|placebo 1
Combination Product|Dietary Supplement|placebo 1
Other|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 149
NA 29
Sweden 29
United Kingdom 19
China 14
Italy 14
France 12
Netherlands 12
Canada 11
Norway 11
Denmark 10
Korea, Republic of 9
United States|Canada 9
Japan 8
Germany 7
Hong Kong 7
Iran, Islamic Republic of 7
Belgium 6
Austria 5
Australia 4
Finland 4
Mexico 4
Pakistan 3
Greece 2
Singapore 2
Spain 2
United States|Australia 2
Argentina 1
Australia|France|Germany 1
Belgium|Germany|Italy|Spain 1
Bulgaria|Czech Republic|Denmark|Germany|Italy|Poland|Spain|Sweden 1
Bulgaria|Czech Republic|Estonia|Germany|Lithuania|Poland|Russian Federation|Ukraine 1
Chile|Mexico 1
Czech Republic|France|Germany|Italy|Poland|Sweden|United Kingdom 1
Denmark|Germany|Latvia|Russian Federation|Ukraine|United Kingdom 1
Egypt 1
France|Spain 1
Hungary|Poland 1
India 1
Ireland 1
Israel 1
Poland 1
Romania 1
Russian Federation 1
South Africa 1
Switzerland 1
Turkey 1
United States|Australia|Canada|China|New Zealand 1
United States|Belgium 1
United States|Belgium|Bulgaria|Canada|Estonia|Germany|Hungary|Israel|Italy|Netherlands|Poland|Serbia|Spain|Ukraine|United Kingdom 1
United States|Bulgaria|Canada|Germany|Hungary|Netherlands|Poland|Spain|United Kingdom 1
United States|Bulgaria|Czech Republic|France|Germany|Italy|Poland|Romania|Russian Federation|Spain|United Kingdom 1
United States|Canada|Puerto Rico|United Kingdom 1
United States|Canada|Sweden|United Kingdom 1
United States|Canada|United Kingdom 1
United States|France|Australia|Canada|Germany|Netherlands|South Africa|Spain|Sweden|United Kingdom| 1
United States|Germany|United Kingdom 1
United States|Ireland|United Kingdom 1

Sites per Study

Site_count Study_Count
1 304
2 27
3 6
4 10
5 3
6 1
7 2
8 1
9 1
11 2
13 1
14 1
15 2
16 3
17 1
18 1
19 2
20 2
21 1
22 1
23 1
29 2
30 1
36 2
41 1
43 2
45 1
48 1
58 1
60 1
61 1
67 1
69 1
71 2
76 1
79 3
80 1
81 1
82 1
83 1
85 1
88 1
96 1
99 1
107 1
111 1
112 1
116 1
117 1
118 2
127 1
135 1
141 1
142 1
155 1
178 1
191 2
204 1
253 1
283 1
288 1
296 1

Phase

Phase Study_Count
N/A 207
Phase 2 87
Phase 3 49
Phase 4 38
Phase 1 15
Phase 2/Phase 3 15
Phase 1/Phase 2 9
Early Phase 1 2

Number of Arms

Number_of_Arms Count_of_Studies
1 54
2 226
3 66
4 29
5 9
6 1
8 2
9 2
11 1
25 1
NA 31

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 20.0 1.0000 7.00000 10.00000 7.0000 10.0000 25.0000 10.0000
1st Qu. 34.5 39.0000 23.00000 40.00000 60.0000 66.5000 169.0000 30.5000
Median 49.0 60.5000 46.00000 52.00000 133.0000 132.0000 577.0000 77.0000
Mean 49.0 107.3447 47.06667 98.44444 207.4235 182.5333 616.2979 158.6579
3rd Qu. 63.5 107.5000 65.00000 128.00000 287.0000 272.0000 757.0000 183.7500
Max. 78.0 3000.0000 100.00000 260.00000 807.0000 462.0000 2583.0000 828.0000

Trial Group Type

group_type Group_Count
Experimental 436
Placebo Comparator 215
Active Comparator 212
No Intervention 34
NA 31
Other 30
Sham Comparator 14

Intervention Model

intervention_model Study_Count
Parallel Assignment 305
Single Group Assignment 59
Crossover Assignment 49
Factorial Assignment 5
Sequential Assignment 2
NA 2

Primary Purpose

primary_purpose Study_Count
Treatment 337
Basic Science 17
Supportive Care 17
Diagnostic 15
NA 14
Other 10
Health Services Research 4
Prevention 4
Screening 4

Observational Studies

Studies by Country

Country Study_Count
United States 31
Netherlands 5
Italy 3
NA 3
United Kingdom 3
Canada 2
China 2
France 2
Germany 2
Japan 2
Switzerland 2
Belgium 1
China|Egypt|Mexico|Poland 1
Denmark 1
Ecuador 1
France|Spain|United Kingdom 1
Iran, Islamic Republic of 1
Israel 1
Korea, Republic of 1
Russian Federation 1
Saudi Arabia 1
Singapore 1
Taiwan 1
United States|Netherlands 1

Sites per Study

Site_count Study_Count
1 55
2 3
3 1
5 1
7 2
8 1
13 1
16 1
24 1
34 1
37 1
47 1
67 1

Enrollment Metrics

Measure Observational
Min 17.000
1st Qu 78.500
Median 150.000
Mean 8371.571
3rd Qu 365.750
Max 440822.000

Observation Model

observational_model Study_Count
Cohort 22
Case Control 16
Case-Control 14
Case-Only 9
Other 4
NA 3
Case-Crossover 1
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 45
Cross-Sectional 16
Retrospective 7
Other 1
NA 1

Registries

Studies by Country

Country Study_Count
Belgium|Netherlands 1
Canada 1
China 1
Indonesia 1
Korea, Republic of 1
Lithuania 1

Sites per Study

Site_count Study_Count
1 5
19 1

Enrollment Metrics

Measure Registries
Min 67.000
1st Qu 237.500
Median 352.500
Mean 1579.333
3rd Qu 466.750
Max 8000.000

Registry Model

observational_model Study_Count
Cohort 4
Ecologic or Community 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 4
Cross-Sectional 2

Follow-up

target_duration Study_Count
5 Years 2
1 Day 1
36 Months 1
6 Months 1
7 Days 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03138980 Mobile Self-Management of Irritable Bowel Syndrome for Adolescents https://ClinicalTrials.gov/show/NCT03138980 Completed University of California, Los Angeles 2016-09-22
NCT04256551 Effects of a Novel Machine Learning Mobile App on Diet Adherence in Individuals Following the Low Fodmap Diet https://ClinicalTrials.gov/show/NCT04256551 Completed Arizona State University 2020-06-01
NCT03379064 Culturally Adapted Psychological Intervention for the Management of Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT03379064 Completed Pakistan Institute of Living and Learning 2017-10-31
NCT03449628 L. Casei DG® in Patients With Irritable Bowel Syndrome. https://ClinicalTrials.gov/show/NCT03449628 Recruiting SOFAR S.p.A. 2019-12-31
NCT03823742 Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program? https://ClinicalTrials.gov/show/NCT03823742 Recruiting Baylor College of Medicine 2022-09-30
NCT03822299 Effects of Faecal Microbiota Transplantation in Patients With IBS https://ClinicalTrials.gov/show/NCT03822299 Completed Helse Fonna 2019-04-30
NCT03359499 Impact of Bacillus Clausii Administration on Irritable Bowel Syndrome Patients https://ClinicalTrials.gov/show/NCT03359499 Completed Hospital Britanico 2017-10-25
NCT03333291 Fecal Transplantation in Patients With IBS https://ClinicalTrials.gov/show/NCT03333291 Completed Haukeland University Hospital 2017-06-15
NCT03332537 Precision Pain Self-Management in Young Adults With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT03332537 Completed University of Connecticut 2018-12-31
NCT03318614 Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster https://ClinicalTrials.gov/show/NCT03318614 Completed Universiti Sains Malaysia 2015-12-31
NCT03306381 The Effect of Dietary Intervention on Symptoms, Epigenetics, and Gut Microbiota in IBS https://ClinicalTrials.gov/show/NCT03306381 Completed Region Skane 2019-02-28
NCT03304041 Efficacy of Low-FODMAPs Dietary Therapy for Irritable Bowel Syndrome in China https://ClinicalTrials.gov/show/NCT03304041 Completed Sir Run Run Shaw Hospital 2018-05-31
NCT03300804 Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome (TCM- IBS) https://ClinicalTrials.gov/show/NCT03300804 Completed University of Maryland, Baltimore 2011-03-31
NCT03270085 Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption https://ClinicalTrials.gov/show/NCT03270085 Completed Mayo Clinic 2019-05-31
NCT03269032 Mediterranean Diet and the Gut Microbiome https://ClinicalTrials.gov/show/NCT03269032 Active, not recruiting Wake Forest University Health Sciences 2020-12-31
NCT03265002 Fibre and Gas in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT03265002 Completed University of Nottingham 2019-10-16
NCT03251625 Multi-strain Probiotic in the Management of IBS-D https://ClinicalTrials.gov/show/NCT03251625 Completed Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 2016-04-30
NCT03245645 FODMAP Reintroduction in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT03245645 Enrolling by invitation University of California, Los Angeles 2020-10-24
NCT03219528 A Longitudinal Study to Identify IBS Phenotypes Using Fecal Microbiota and Hydrogen Breath Testing https://ClinicalTrials.gov/show/NCT03219528 Recruiting University of Michigan 2021-12-31
NCT03186872 Improving Quality of Care With a Digital Behavioral Program in IBD Patient Centered Medical Home https://ClinicalTrials.gov/show/NCT03186872 Completed University of Pittsburgh 2019-05-29
NCT03154086 A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers https://ClinicalTrials.gov/show/NCT03154086 Completed GlaxoSmithKline 2018-03-05
NCT03150212 Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype https://ClinicalTrials.gov/show/NCT03150212 Completed Lesaffre International 2019-05-09
NCT03125564 FMT for Patients With IBS With Fecal and Mucosal Microbiota Assessment https://ClinicalTrials.gov/show/NCT03125564 Active, not recruiting Chinese University of Hong Kong 2020-12-31
NCT03099785 Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D https://ClinicalTrials.gov/show/NCT03099785 Recruiting Cosmo Pharmaceuticals NV 2020-05-31
NCT03087799 Brief Behavioral Treatment for Sleep Problems in IBS Study https://ClinicalTrials.gov/show/NCT03087799 Completed Beth Israel Deaconess Medical Center 2019-08-08
NCT03078634 The Multi-disciplinary Treatment of Functional Gut Disorders Study https://ClinicalTrials.gov/show/NCT03078634 Active, not recruiting St Vincent’s Hospital Melbourne 2019-02-28
NCT03074227 The FAIS-Trial: Faecal Microbiota Transplantation (FMT) in Adolescents With Refractory Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT03074227 Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2021-04-01
NCT04454996 Study on the Rule and Mechanism of Treating Functional Gastrointestinal Diseases From the Perspective of Liver and Spleen https://ClinicalTrials.gov/show/NCT04454996 Recruiting Xiyuan Hospital of China Academy of Chinese Medical Sciences 2021-09-30
NCT03054506 The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation https://ClinicalTrials.gov/show/NCT03054506 Completed Massachusetts General Hospital 2018-05-10
NCT03052439 Diet Reintroduction Study in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT03052439 Recruiting University of Michigan 2020-10-31
NCT03046667 Effect of 6 Weeks Daily Consumption of a Cereal-based Juice Beverage on Gastrointestinal Health https://ClinicalTrials.gov/show/NCT03046667 Completed University of Copenhagen 2017-07-20
NCT03035799 Comparing Two Types of Diets on Psychological and Gastrointestinal Symptoms https://ClinicalTrials.gov/show/NCT03035799 Completed Johns Hopkins University 2020-04-01
NCT03019861 Ayurvedic Nutritional Counseling for Patients With IBS in Comparison to Conventional Nutritional Counseling https://ClinicalTrials.gov/show/NCT03019861 Completed Charite University, Berlin, Germany 2018-10-31
NCT03011593 Effect of UGIR in Adults With Compromised Gut Function and Malabsorption https://ClinicalTrials.gov/show/NCT03011593 Completed Metagenics, Inc. 2016-06-30
NCT02980406 The Role of FODMAPs in Upper GI Effects, Colonic Motor Activity and Gut-brain Signaling at the Behavioral Level https://ClinicalTrials.gov/show/NCT02980406 Completed Universitaire Ziekenhuizen Leuven 2016-06-30
NCT02977975 Lacto-fermented Sauerkraut in the Treatment of Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02977975 Completed University of Copenhagen 2017-03-31
NCT02970591 A Comparison of Three Different Treatment Options for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02970591 Recruiting Sahlgrenska University Hospital, Sweden 2021-12-31
NCT02959983 Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use https://ClinicalTrials.gov/show/NCT02959983 Completed Allergan 2018-01-22
NCT02932111 Irritable Bowel Syndrome and Osteopathic Manipulative Therapy https://ClinicalTrials.gov/show/NCT02932111 Recruiting Assistance Publique - Hôpitaux de Paris 2021-07-12
NCT02924493 Dietary Treatment of Endometriosis-related Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02924493 Completed University of Aarhus 2017-12-01
NCT02888392 The Effect of Zespri Green Kiwifruit on Digestive and Gut Health Functions https://ClinicalTrials.gov/show/NCT02888392 Completed Zespri International Limited 2017-01-30
NCT03226145 Reclassifying Constipation Using Imaging and Manometry https://ClinicalTrials.gov/show/NCT03226145 Recruiting University of Nottingham 2020-09-30
NCT02880332 Pain Processing and Pain Neuroscience Education in Children With Chronic Abdominal Pain https://ClinicalTrials.gov/show/NCT02880332 Completed Vrije Universiteit Brussel 2018-10-04
NCT02875847 Effects of HMOs on Faecal Microbiota, Gastrointestinal Symptoms, Mucosal Immunity and Barrier Function in IBS Patients https://ClinicalTrials.gov/show/NCT02875847 Completed Glycom A/S 2018-07-31
NCT02868983 Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems https://ClinicalTrials.gov/show/NCT02868983 Enrolling by invitation University of Vermont 2021-04-30
NCT02857257 Transplantation of Anaerobic Cultured Human Intestinal Microbiota in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02857257 Recruiting Uppsala University 2018-12-31
NCT02847481 A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBS https://ClinicalTrials.gov/show/NCT02847481 Completed Beth Israel Deaconess Medical Center 2018-08-05
NCT02822118 Therapeutic Effect of Chang’an I Recipe on Irritable Bowel Syndrome With Diarrhea https://ClinicalTrials.gov/show/NCT02822118 Completed Xiyuan Hospital of China Academy of Chinese Medical Sciences 2015-12-31
NCT02802241 Effects of Open-label vs Double-blind Treatment in IBS https://ClinicalTrials.gov/show/NCT02802241 Completed Beth Israel Deaconess Medical Center 2019-01-31
NCT02798991 A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal Subjects https://ClinicalTrials.gov/show/NCT02798991 Completed GlaxoSmithKline 2016-11-30
NCT02794376 Mindfulness for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02794376 Completed University of Oxford 2017-07-10
NCT02788071 Effect of Fecal Microbiota Transplantation in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02788071 Completed Aleris-Hamlet Hospitaler København 2017-07-31
NCT02757105 Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) https://ClinicalTrials.gov/show/NCT02757105 Completed RedHill Biopharma Limited 2017-06-16
NCT02737410 Resilience in Irritable Bowel Syndrome and Gut-focused Hypnotherapy https://ClinicalTrials.gov/show/NCT02737410 Completed Medical University of Vienna 2014-06-30
NCT02732743 Food Supplement Physiomanna® Baby in Pediatric Patients https://ClinicalTrials.gov/show/NCT02732743 Completed Iuppa Industriale Srl 2016-04-30
NCT02727751 A Long-Term Safety Study of Tenapanor for the Treatment of IBS-C https://ClinicalTrials.gov/show/NCT02727751 Completed Ardelyx 2017-10-31
NCT02727283 A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy Volunteers https://ClinicalTrials.gov/show/NCT02727283 Completed GlaxoSmithKline 2016-03-18
NCT02716285 Peppermint Oil for the Treatment of Irritable Bowel Syndrome: Optimizing Therapeutic Strategies Using Targeted Delivery https://ClinicalTrials.gov/show/NCT02716285 Completed Maastricht University Medical Center 2018-05-01
NCT02706483 Long Term Safety Study of Plecanatide https://ClinicalTrials.gov/show/NCT02706483 Completed Bausch Health Americas, Inc. 2017-05-31
NCT02686138 A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C https://ClinicalTrials.gov/show/NCT02686138 Completed Ardelyx 2017-08-31
NCT02681666 Mindfulness-Based Eating in Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02681666 Completed University of Miami 2017-12-26
NCT02657668 Emotion Focused Therapy in Irritable Bowel Syndrome Patients https://ClinicalTrials.gov/show/NCT02657668 Completed Islamic Azad University, Najafabad Branch 2014-01-31
NCT02653937 The Effect of Shigyakusan Used for IBS and MUPS Diagnosed by Abdominal N Line Tenderness https://ClinicalTrials.gov/show/NCT02653937 Completed Nakatani Clinic 2015-02-28
NCT02651740 Gut Microbiota Reconstruction in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea https://ClinicalTrials.gov/show/NCT02651740 Recruiting Shanghai Zhongshan Hospital 2020-04-30
NCT02621892 A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C https://ClinicalTrials.gov/show/NCT02621892 Completed Ardelyx 2017-03-31
NCT02614313 Fructose Breath-testing in Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT02614313 Completed Brain-Gut Research Group 2017-08-31
NCT02609529 SBI in Children With d-IBS https://ClinicalTrials.gov/show/NCT02609529 Completed Louisiana State University Health Sciences Center in New Orleans 2017-03-31
NCT02590432 An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation https://ClinicalTrials.gov/show/NCT02590432 Completed Forest Laboratories 2018-02-05
NCT02572908 Effects of Wheat Breads on Symptoms of IBS, a Pilot Study https://ClinicalTrials.gov/show/NCT02572908 Completed Oy Karl Fazer Ab 2016-03-31
NCT03721107 A Trial for New Treatment of Adult Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT03721107 Completed 4D pharma plc 2020-05-15
NCT02566876 Bifidobacteria In Children With Abdominal Pain-Associated Functional Gastrointestinal Disorders https://ClinicalTrials.gov/show/NCT02566876 Completed Federico II University 2015-07-31
NCT02559245 Effect of Flixweed and Fig on Irritable Bowel Syndrome With Predominant Constipation: a Single Blind Randomized Clinical Trial. https://ClinicalTrials.gov/show/NCT02559245 Completed Isfahan University of Medical Sciences 2016-01-31
NCT02559206 Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) https://ClinicalTrials.gov/show/NCT02559206 Completed Ironwood Pharmaceuticals, Inc. 2016-09-30
NCT02877654 Is There Any Correlation Between Plasmatic Zonulin and Expression of Intestinal Tight Junction Proteins in IBS Patients? https://ClinicalTrials.gov/show/NCT02877654 Recruiting University Hospital, Rouen 2021-02-28
NCT02551029 fMRI and Visceral Perception Upon Capsaicin Infusion https://ClinicalTrials.gov/show/NCT02551029 Completed Maastricht University Medical Center 2019-07-26
NCT02538692 Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02538692 Completed Chengdu University of Traditional Chinese Medicine 2017-01-31
NCT02536131 Intestinal Microbiome and Psychological Correlates in Irritable Bowel Syndrome and Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02536131 Completed Medical University of Vienna 2016-08-31
NCT02528929 Gluten-free Diet in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02528929 Completed Sheffield Teaching Hospitals NHS Foundation Trust 2018-07-31
NCT02493452 Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C) https://ClinicalTrials.gov/show/NCT02493452 Completed Bausch Health Americas, Inc. 2016-11-30
NCT02493036 A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-C https://ClinicalTrials.gov/show/NCT02493036 Completed Synthetic Biologics Inc. 2015-12-31
NCT02450370 Diets in Symptom Relief and the Influence of Quality of Life in People With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02450370 Completed Hong Kong Sanatorium & Hospital 2017-11-20
NCT02436603 Integrative Approaches to Managing Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT02436603 Completed Beth Israel Medical Center 2017-06-28
NCT02431533 The Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02431533 Completed Pharmabiotix Inc 2018-08-31
NCT02421627 Moxibustion for Diarrhea-predominant Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02421627 Completed Shanghai Institute of Acupuncture, Moxibustion and Meridian 2018-12-31
NCT02420158 Trans-cutaneous Vagal Nerve Electrical Stimulation and Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02420158 Completed Hospices Civils de Lyon 2018-08-31
NCT02419963 Analyzing IBS to Identify Biomarkers and Microbiome Signatures https://ClinicalTrials.gov/show/NCT02419963 Completed Mayo Clinic 2016-12-12
NCT02391220 Assessment of the Symbiotic Fermented Milk in Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02391220 Completed Clinres Farmacija d.o.o. 2013-01-31
NCT02389998 Efficacy of Open Label Placebo in Children With FGIDs https://ClinicalTrials.gov/show/NCT02389998 Recruiting Boston Children’s Hospital 2018-12-31
NCT02388269 A Randomized, Single Centre, Double-blind, Parallel, Sham-controlled Pilot Study Using gammaCore®-G https://ClinicalTrials.gov/show/NCT02388269 Completed ElectroCore INC 2015-05-31
NCT02387359 The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) https://ClinicalTrials.gov/show/NCT02387359 Completed Bausch Health Americas, Inc. 2016-12-31
NCT02372201 Effects of Fasting and Hydro Colon Therapy Plus Probiotics on GI Microbiota in Intolerances and Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02372201 Completed University of Vienna 2014-06-30
NCT02371499 Effect of Lactobacillus Casei DG (Enterolactis Plus®) in Patient With Irritable Bowel Syndrome: a Pilot Study https://ClinicalTrials.gov/show/NCT02371499 Completed SOFAR S.p.A. 2015-11-30
NCT02364830 Clinical Effectiveness of Enteric Coated(E.C.) Anise-oil on Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02364830 Completed Shiraz University of Medical Sciences 2015-01-31
NCT02358694 Safety and Tolerability of Serum Derived Bovine Immunoglobulin in Children With Diarrhea Predominant IBS https://ClinicalTrials.gov/show/NCT02358694 Completed Connecticut Children’s Medical Center 2015-06-01
NCT02358564 Gut Permeability, Sensitivity and Symptomatology https://ClinicalTrials.gov/show/NCT02358564 Active, not recruiting Mayo Clinic 2020-08-31
NCT02328547 Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02328547 Completed Montefiore Medical Center 2017-10-31
NCT02316899 Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02316899 Completed Astellas Pharma Inc 2015-09-19
NCT02306369 Internet-delivered CBT for Irritable Bowel Syndrome in Adolescents https://ClinicalTrials.gov/show/NCT02306369 Completed Karolinska Institutet 2016-05-31
NCT02299973 Fecal Microbiota Transplantation in Irritable Bowel Syndrome With Bloating https://ClinicalTrials.gov/show/NCT02299973 Completed University Hospital, Ghent 2017-12-31
NCT02294760 Long-term Sacral Nerve Stimulation for Irritable Bowel Syndrome. https://ClinicalTrials.gov/show/NCT02294760 Completed University of Aarhus 2016-12-31
NCT02291445 Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®), a Pharmacokinetic Study https://ClinicalTrials.gov/show/NCT02291445 Completed Maastricht University Medical Center 2015-07-31
NCT02270268 Effects of Pectin Supplementation in Diarrhea-predominant Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02270268 Completed Nanjing PLA General Hospital 2013-10-31
NCT02259465 The Effect of the Low FODMAP Diet and Dietary Oligofructose on Gastrointestinal Form, Function and Microbiota https://ClinicalTrials.gov/show/NCT02259465 Completed University of Nottingham 2014-12-31
NCT02254629 The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients https://ClinicalTrials.gov/show/NCT02254629 Completed Shandong University 2015-08-31
NCT02251483 Use of SBI in IBS Subjects Following a Successful Treatment of Small Intestinal Bacterial Overgrowth https://ClinicalTrials.gov/show/NCT02251483 Completed Cedars-Sinai Medical Center 2015-07-31
NCT02242175 Efficacy of Hydrogen Breath Test in the Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02242175 Recruiting Yonsei University 2020-08-31
NCT02220348 A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide Therapeutically https://ClinicalTrials.gov/show/NCT02220348 Completed Forest Laboratories 2019-05-31
NCT02213172 Evaluation of the Efficacy of Two Probiotic Strains for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02213172 Completed KGK Science Inc. 2018-02-15
NCT02204891 Probiotics in Intestinal Bacterial Overgrowth https://ClinicalTrials.gov/show/NCT02204891 Completed University of Athens 2016-06-30
NCT02163213 Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Bid on Nutritional Status in Subjects With IBS-D https://ClinicalTrials.gov/show/NCT02163213 Completed Mayo Clinic 2016-11-01
NCT02161120 Effect of Two Different Rye Bread Types in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02161120 Completed Oy Karl Fazer Ab 2015-02-28
NCT02136745 Effects of Relaxation Response Mind-body Intervention in Patients With IBS and IBD https://ClinicalTrials.gov/show/NCT02136745 Completed Massachusetts General Hospital 2011-07-31
NCT02113605 Cognitive Behavior Therapy (CBT) for Children With Functional Gastrointestinal Disorders https://ClinicalTrials.gov/show/NCT02113605 Completed Karolinska Institutet 2015-11-30
NCT02111603 Ability of Mayo Clinic High-performance Liquid Chromatography (HPLC) Method to Measure Fecal Bile Acids https://ClinicalTrials.gov/show/NCT02111603 Completed Mayo Clinic 2014-08-31
NCT02108119 The Effect of Probiotics on Symptoms and Intestinal Flora in Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02108119 Completed Probi AB 2015-11-30
NCT02107625 Traditional Dietary Advice Versus a Low FODMAP Diet Intake in IBS Patients https://ClinicalTrials.gov/show/NCT02107625 Completed Göteborg University 2015-01-31
NCT02107196 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) https://ClinicalTrials.gov/show/NCT02107196 Completed Menarini Group 2015-06-30
NCT02092402 Fecal Microbiota Transplantation in Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02092402 Completed Örebro University, Sweden 2016-11-30
NCT02079857 Symptom Management for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02079857 Recruiting NYU Langone Health 2019-11-30
NCT02079675 Study to Assess the Efficacy and Safety of SKI3246 in Subjects With Non-Constipation Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02079675 Completed SK Chemicals Co., Ltd. 2014-03-31
NCT02078323 Investigation of Linaclotide’s Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients https://ClinicalTrials.gov/show/NCT02078323 Completed Augusta University 2017-10-04
NCT02077699 Efficacy Evaluation of a Commercial Preparation Containing Lactobacillus Casei DG on the Reduction of the Painful Symptoms Related to the Irritable Bowel Syndrome (IBS). A Pilot Clinical Study https://ClinicalTrials.gov/show/NCT02077699 Completed SOFAR S.p.A. 2014-06-30
NCT02026518 Effect of Cholecalciferol, Soy Isoflavones in Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02026518 Completed Shahid Beheshti University of Medical Sciences 2014-04-30
NCT02074579 A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02074579 Completed Tsumura USA 2016-04-30
NCT01316718 Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D) https://ClinicalTrials.gov/show/NCT01316718 Completed University of Nottingham 2013-09-30
NCT01303224 Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D) https://ClinicalTrials.gov/show/NCT01303224 Completed Menarini Group 2012-05-31
NCT01279382 Effect of Hypnotherapy in Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT01279382 Completed Maastricht University Medical Center NA
NCT01276626 Study of Bacteria on Mood and Bowel Symptoms in Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01276626 Completed Nestlé 2014-06-30
NCT01274000 A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female Patients https://ClinicalTrials.gov/show/NCT01274000 Completed Astellas Pharma Inc 2011-10-31
NCT02033161 Internet-delivered Cognitive Behavior Therapy for Adolescents With Functional Gastrointestinal Disorders: a Pilot Study https://ClinicalTrials.gov/show/NCT02033161 Completed Karolinska Institutet 2013-06-30
NCT02009618 The Effects of Rifaximin Therapy in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02009618 Completed Bezmialem Vakif University 2013-10-31
NCT01950715 Multimodal Stimulation Before and After Sacral Nerve Stimulation for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01950715 Completed University of Aarhus 2018-03-31
NCT01948973 Subsensory Sacral Nerve Stimulation for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01948973 Completed University of Aarhus 2018-03-31
NCT01923428 The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C) https://ClinicalTrials.gov/show/NCT01923428 Completed Ardelyx 2014-10-31
NCT04373304 The Effect of a Low FODMAP Diet in Irritable Bowel Syndrome Patients https://ClinicalTrials.gov/show/NCT04373304 Recruiting Universitaire Ziekenhuizen Leuven 2021-07-01
NCT01896583 A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) https://ClinicalTrials.gov/show/NCT01896583 Completed Seldar Pharma, Inc. 2014-03-31
NCT01890837 Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT01890837 Completed Tsumura USA 2015-03-31
NCT01887834 Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01887834 Completed The Canadian College of Naturopathic Medicine 2014-06-30
NCT01886781 Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01886781 Completed University of Stellenbosch 2013-06-30
NCT01886027 Stress Management for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01886027 Completed Wayne State University 2015-03-31
NCT01880424 A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) https://ClinicalTrials.gov/show/NCT01880424 Completed AstraZeneca 2015-05-31
NCT01870895 A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT01870895 Completed Astellas Pharma Inc 2014-02-28
NCT01855711 Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT01855711 Completed GlaxoSmithKline 2005-05-10
NCT01844180 A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) https://ClinicalTrials.gov/show/NCT01844180 Completed Ono Pharmaceutical Co. Ltd 2014-07-31
NCT01837485 Probiotics in the Treatment of Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01837485 Completed Islamic Azad University, Najafabad Branch 2013-01-31
NCT01837472 Probiotics in the Treatment of Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01837472 Completed Isfahan University of Medical Sciences 2013-01-31
NCT01815164 Effect of Hypnotherapy and Educational Intervention in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01815164 Completed University Hospital, Linkoeping 2011-09-30
NCT01801605 Repetitive Transcranial Magnetic Stimulation in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01801605 Completed University Hospital, Rouen 2013-01-31
NCT01791621 The Diagnostic Predictability of Food Allergy Testing https://ClinicalTrials.gov/show/NCT01791621 Completed The Canadian College of Naturopathic Medicine 2013-04-30
NCT01786109 Effect of a Cannabinoid Agonist on Colonic Sensory Functions in Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01786109 Completed Mayo Clinic 2011-12-31
NCT01776853 Fructose and Fructans in Irritabla Bowel Syndrome https://ClinicalTrials.gov/show/NCT01776853 Completed University of Nottingham 2015-02-28
NCT01774825 IQP-CL-101 in IBS Management https://ClinicalTrials.gov/show/NCT01774825 Completed InQpharm Group 2014-02-28
NCT01774695 Physical Activity in IBS - a Long Term Follow up https://ClinicalTrials.gov/show/NCT01774695 Completed Sahlgrenska University Hospital, Sweden 2011-09-30
NCT01754493 Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression https://ClinicalTrials.gov/show/NCT01754493 Completed New York State Psychiatric Institute 2014-12-31
NCT01736423 A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01736423 Completed Astellas Pharma Inc 2014-05-31
NCT01728610 Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal Symptoms https://ClinicalTrials.gov/show/NCT01728610 Completed Danisco 2014-11-30
NCT01726751 Spinal Cord Stimulation for Pain Relief in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01726751 Completed Uppsala University 2014-04-30
NCT01714843 A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01714843 Completed Astellas Pharma Inc 2013-12-07
NCT01699438 Mesalazine Treatment in IBS (The MIBS Study) https://ClinicalTrials.gov/show/NCT01699438 Completed Göteborg University 2016-12-31
NCT01641341 Irritable Bowel Syndrome Evaluation and Treatment in Primary Care https://ClinicalTrials.gov/show/NCT01641341 Completed American Academy of Family Physicians 2012-03-31
NCT01631500 Effects of an Integrative Treatment Model to Reduce Anxiety and Depression in Minor Mental Health Problems and Medically Unexplained Symptoms https://ClinicalTrials.gov/show/NCT01631500 Completed Göteborg University 2011-01-31
NCT01624610 Comparing the Effectiveness of 2 Diets for Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01624610 Completed University of Michigan 2015-10-31
NCT01622972 Mode of Action of Moviprep https://ClinicalTrials.gov/show/NCT01622972 Completed University of Nottingham 2014-02-28
NCT01619384 Mindfulness-Based Stress Reduction and the Microbiome https://ClinicalTrials.gov/show/NCT01619384 Completed Seattle Institute for Biomedical and Clinical Research 2013-12-31
NCT01613456 Effect of Saccharomyces Cerevisiae on the Symptoms of Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01613456 Completed Lesaffre International 2013-06-30
NCT01602575 Neuroimaging and Biomarkers in Chronic Visceral Pain https://ClinicalTrials.gov/show/NCT01602575 Completed University of California, Los Angeles 2016-03-20
NCT01553747 Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) https://ClinicalTrials.gov/show/NCT01553747 Completed Furiex Pharmaceuticals, Inc 2014-01-09
NCT01553591 Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) https://ClinicalTrials.gov/show/NCT01553591 Completed Furiex Pharmaceuticals, Inc 2014-07-29
NCT01551225 Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder https://ClinicalTrials.gov/show/NCT01551225 Completed Maastricht University Medical Center 2016-09-30
NCT01545037 Effect of BIO-K+ on Symptoms of Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01545037 Completed Bio-K Plus International Inc. 2015-01-31
NCT01543178 Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study https://ClinicalTrials.gov/show/NCT01543178 Completed Bausch Health Americas, Inc. 2014-06-30
NCT01529567 Cognitive Behavioral Therapy With Our Without Exposure Therapy for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01529567 Completed Karolinska Institutet 2012-12-31
NCT01507922 Comparative Efficacy and Safety of Fenoverine https://ClinicalTrials.gov/show/NCT01507922 Completed Bukwang Pharmaceutical 2013-03-31
NCT01505777 Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea https://ClinicalTrials.gov/show/NCT01505777 Completed Hanmi Pharmaceutical Company Limited 2012-06-30
NCT01494233 A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01494233 Completed Lexicon Pharmaceuticals 2013-09-30
NCT01483287 The Effects of Added Enzyme α-Galactosidase at a Carbohydrate-rich Meal in Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT01483287 Completed Sahlgrenska University Hospital, Sweden 2013-06-30
NCT01418066 Ayurvedic Herbs in Diarrhea Predominant Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01418066 Completed Universität Duisburg-Essen 2012-12-31
NCT01418053 The Effect of Hot Cataplasm With Caraway Oil in the Treatment of Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01418053 Completed Universität Duisburg-Essen 2013-09-30
NCT01414244 Glutamine for the Treatment of Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01414244 Completed Tulane University 2015-12-30
NCT01412372 The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study https://ClinicalTrials.gov/show/NCT01412372 Completed University of Utah 2019-04-22
NCT01411800 An Open-Label Study of Two Formulations of LX1033 in Healthy Human Subjects https://ClinicalTrials.gov/show/NCT01411800 Completed Lexicon Pharmaceuticals 2011-10-31
NCT01404923 Effectiveness of On-demand Meteospasmyl® Use in Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT01404923 Completed Laboratoires Mayoly Spindler 2011-10-31
NCT01403493 Multidisciplinary Versus a Nurse Based Patient Education For Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01403493 Completed Sahlgrenska University Hospital, Sweden 2011-07-31
NCT01400048 Aloe Vera in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01400048 Completed Sahlgrenska University Hospital, Sweden 2016-12-31
NCT01350570 Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT01350570 Completed Chengdu University of Traditional Chinese Medicine 2014-02-28
NCT01342718 Effect of Herbal Extract Granules Combined With Probiotics on Irritable Bowel Syndrome With Diarrhea https://ClinicalTrials.gov/show/NCT01342718 Completed Kyunghee University Medical Center 2012-04-30
NCT01340053 A Study to Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C) https://ClinicalTrials.gov/show/NCT01340053 Completed Ardelyx 2011-12-31
NCT01331213 Pregabalin on Colonic Motor and Sensory Function in Constipation Predominant Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01331213 Completed Mayo Clinic 2013-02-28
NCT01327300 Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS) https://ClinicalTrials.gov/show/NCT01327300 Completed University of Florida 2012-03-31
NCT04422327 The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT04422327 Completed PrecisionBiotics Ltd. 2018-02-12
NCT04387383 Acupuncture for Irritable Bowel Syndrome Patients https://ClinicalTrials.gov/show/NCT04387383 Recruiting Hong Kong Baptist University 2021-04-30
NCT04348760 Study of Inflammatory Markers and Symptom Severity in Personalized Nutritional Intervention in IBS https://ClinicalTrials.gov/show/NCT04348760 Completed GEK Srl 2019-07-30
NCT04340661 Effects of a Food Supplement Composed by BIOintestil ® (Bionocol®) on Microbiota and Inflammatory Profile in Irritable Bowel Syndrome Patients https://ClinicalTrials.gov/show/NCT04340661 Recruiting Targeting Gut Disease S.R.L. 2020-09-30
NCT04307368 The Impact of Dietary Treatment in Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT04307368 Completed Medical University of Bialystok 2018-12-31
NCT04283487 Brain and Gut Responses to Intragastric Administration of FODMAPs in Healthy Subjects and Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT04283487 Recruiting Universitaire Ziekenhuizen Leuven 2020-06-30
NCT04270487 The DOMINO Trial: Diet Or Medication in Irritable Bowel syNdrOme https://ClinicalTrials.gov/show/NCT04270487 Recruiting Universitaire Ziekenhuizen Leuven 2020-03-01
NCT04245254 GutMe!: IBS and Collagen Protein Powder an Interventional Study https://ClinicalTrials.gov/show/NCT04245254 Recruiting ProofPilot 2020-08-01
NCT04236843 Faecal Microbiota Transplantation (FMT) in Patients With IBSmechanism(s) of Action https://ClinicalTrials.gov/show/NCT04236843 Recruiting Helse Fonna 2020-12-31
NCT04225104 Yogic Breathing and IBS https://ClinicalTrials.gov/show/NCT04225104 Recruiting Texas State University 2020-02-01
NCT04217733 Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT04217733 Recruiting Tanta University 2030-12-01
NCT04206410 Effectiveness of Probiotics Stabilized With Cryoprotection Technology in Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT04206410 Completed Children’s Memorial Health Institute, Poland 2019-09-10
NCT04193501 Frequency of Sleep Abnormalities in Patients With Irritable Bowel Syndrome and Effect of Pharmacological Intervention https://ClinicalTrials.gov/show/NCT04193501 Recruiting Sanjay Gandhi Postgraduate Institute of Medical Sciences 2021-02-28
NCT04170686 Acceptability and Efficacy of the Zemedy App for IBS https://ClinicalTrials.gov/show/NCT04170686 Recruiting University of Pennsylvania 2020-10-28
NCT04159311 Osteopathy on IBS Symptoms in Patients With Ulcerative Colitis in Remission https://ClinicalTrials.gov/show/NCT04159311 Recruiting Clinique Paris-Bercy 2021-11-02
NCT04145856 Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico https://ClinicalTrials.gov/show/NCT04145856 Completed Hospital Juarez de Mexico 2019-05-02
NCT04143633 Low FODMAP Diet on Nutritional Status, Disease Activity and Gut Microbiota in IBS and UC With Normal or Overweight BMI https://ClinicalTrials.gov/show/NCT04143633 Recruiting Hospital General de Mexico 2020-08-31
NCT04138186 G-PUR® for Symptomatic Treatment in Irritable Bowel Syndrome With Diarrhea https://ClinicalTrials.gov/show/NCT04138186 Recruiting Glock Health, Science and Research GmbH 2020-08-31
NCT04133519 Efficacy and Safety of IBS Digital Behavioral Treatment https://ClinicalTrials.gov/show/NCT04133519 Recruiting metaMe Health 2020-06-30
NCT04132804 Effect of Tai Chi as Treatment for IBS-C https://ClinicalTrials.gov/show/NCT04132804 Recruiting Massachusetts General Hospital 2021-08-01
NCT04129762 Effect of a Diet Without Non-caloric Sweeteners on Gastrointestinal Symptoms in Patients With IBS and Dyspepsia https://ClinicalTrials.gov/show/NCT04129762 Recruiting Hospital General de Mexico 2020-08-31
NCT04122586 Mechanism of PERK - eIF2a Pathways in Intestinal Mucosal Barrier of IBS-D and the Role “Metabolism Ingredients” of Tongxieyaofang https://ClinicalTrials.gov/show/NCT04122586 Recruiting Xiyuan Hospital of China Academy of Chinese Medical Sciences 2020-12-31
NCT03339128 Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children. https://ClinicalTrials.gov/show/NCT03339128 Recruiting Allergan 2023-01-01
NCT04095988 Allogeneic Microbiota-reconstitution (AMR) in Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) https://ClinicalTrials.gov/show/NCT04095988 Active, not recruiting University of Ulm 2020-12-31
NCT04072991 A Study Comparing the Effectiveness and Convenience of Dietary Therapy for Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT04072991 Active, not recruiting Sheffield Teaching Hospitals NHS Foundation Trust 2020-11-30
NCT04053790 Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D) https://ClinicalTrials.gov/show/NCT04053790 Recruiting Hospital General de Mexico 2020-01-31
NCT04043455 Olorinab in IBS-C and IBS-D https://ClinicalTrials.gov/show/NCT04043455 Recruiting Arena Pharmaceuticals 2020-12-31
NCT04043208 Treatment of Functional Abdominal Distension https://ClinicalTrials.gov/show/NCT04043208 Recruiting Hospital Universitari Vall d’Hebron Research Institute 2020-06-19
NCT04037826 L. Reuteri DSM 17938 and L. Reuteri ATCC PTA 6475 in Moderate to Severe Irritable Bowel in Adults https://ClinicalTrials.gov/show/NCT04037826 Active, not recruiting Innovacion y Desarrollo de Estrategias en Salud 2018-09-30
NCT04017585 Identification of Gluten Sensitivity in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT04017585 Completed University of Bari 2019-09-30
NCT04014413 Safety and Efficacy of Fecal Microbiota Transplantation https://ClinicalTrials.gov/show/NCT04014413 Recruiting Chinese University of Hong Kong 2023-10-31
NCT04011943 Fecal Microbiota Transplantation for Health Improvement (TFM3) https://ClinicalTrials.gov/show/NCT04011943 Enrolling by invitation Federal Research and Clinical Center of Physical-Chemical Medicine 2020-12-01
NCT04008901 The Efficacy and Safety of “BST104” (Lonicera Flos Extract) in Mild to Moderate Functional Dyspepsia Subjects https://ClinicalTrials.gov/show/NCT04008901 Completed Seoul National University Bundang Hospital 2018-07-02
NCT03997708 A Mediterranean Approach to Low FODMAP Diet (MED-LFD) for Managing IBS Symptoms https://ClinicalTrials.gov/show/NCT03997708 Recruiting Attikon Hospital 2021-06-03
NCT03986476 The Effect of Two Probiotic Products on the Intestinal Barrier Function in Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT03986476 Recruiting Örebro University, Sweden 2020-06-30
NCT03977155 Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) https://ClinicalTrials.gov/show/NCT03977155 Active, not recruiting Boston Pharmaceuticals 2020-04-30
NCT03964103 qQ-lab Daily-IBS for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT03964103 Completed IlDong Pharmaceutical Co Ltd 2017-11-08
NCT03948854 Implementing a Low FODMAP Diet in Irritable Bowel Syndrome Patients https://ClinicalTrials.gov/show/NCT03948854 Enrolling by invitation Mayo Clinic 2020-05-22
NCT03931785 A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT03931785 Completed Ironwood Pharmaceuticals, Inc. 2020-02-26
NCT03931330 Does Improving Vagal Tone Increase Mitochondrial Bioenergetics https://ClinicalTrials.gov/show/NCT03931330 Completed Medical College of Wisconsin 2019-09-24
NCT03920410 Effect of Serotonergic Stimulation on the Gut-brain Axis https://ClinicalTrials.gov/show/NCT03920410 Recruiting Örebro University, Sweden 2020-12-31
NCT03899779 Face-to-face Versus Online Hypnotherapy for the Treatment of Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT03899779 Recruiting Maastricht University Medical Center 2022-08-31
NCT03869359 The Effect of Gluten in Patients With Irritable Bowel Syndrome and Healthy Volunteers https://ClinicalTrials.gov/show/NCT03869359 Recruiting Sahlgrenska University Hospital, Sweden 2019-10-01
NCT03844412 Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments https://ClinicalTrials.gov/show/NCT03844412 Recruiting Duke University 2022-10-01
NCT03817645 Panaceo “MED” for IBS (Irritable Bowel Syndrome) https://ClinicalTrials.gov/show/NCT03817645 Recruiting Scigenia GmbH 2019-06-30
NCT03815617 A Novel Formulation of Bifidobacterium Longum BB536 and Lactobacillus Rhamnosus HN001 With Vitamin B6 on IBS Patients https://ClinicalTrials.gov/show/NCT03815617 Completed University of Bari 2018-05-31
NCT03806959 Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy https://ClinicalTrials.gov/show/NCT03806959 Recruiting Hospital Avicenne 2020-11-07
NCT03806127 Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT03806127 Recruiting Urovant Sciences GmbH 2020-09-30
NCT03803319 Effects of Dietary Fibre in Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT03803319 Completed King’s College London 2020-01-11
NCT03801057 Marine Protein Hydrolysate as Dietary Supplement in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT03801057 Completed Helse Møre og Romsdal HF 2019-03-21
NCT03763175 Efficacy and Safety of SYN-010 in IBS-C https://ClinicalTrials.gov/show/NCT03763175 Recruiting Cedars-Sinai Medical Center 2020-10-30
NCT03729622 Carbohydrate Reduction and Impact on Gastrointestinal System https://ClinicalTrials.gov/show/NCT03729622 Completed University of Nottingham 2017-07-31
NCT03729271 Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea https://ClinicalTrials.gov/show/NCT03729271 Recruiting University of Michigan 2021-01-01
NCT03694223 Health Education Delivery Methods for a Low Fermentable Carbohydrate Diet in Patients With Functional Bowel Disorders https://ClinicalTrials.gov/show/NCT03694223 Completed King’s College London 2018-10-25
NCT03687814 Low FODMAP Plus PEG 3350 for the Treatment of Patients With Irritable Bowel Syndrome-Constipation https://ClinicalTrials.gov/show/NCT03687814 Recruiting University of Michigan 2020-11-03
NCT03678935 Effect of FODMAP Restriction on Persistent GI-symptoms in Coeliac Patients https://ClinicalTrials.gov/show/NCT03678935 Active, not recruiting Oslo University Hospital 2019-06-01
NCT03675100 Neurotrophic Factors, Tight Junction Proteins, and Cytokines in IBS https://ClinicalTrials.gov/show/NCT03675100 Completed Seoul National University Bundang Hospital 2019-12-31
NCT03664531 Dietary Triggers of Gastrointestinal Symptoms in IBS Patients https://ClinicalTrials.gov/show/NCT03664531 Recruiting McMaster University 2020-08-31
NCT03644602 Low FODMAPs Diet in Gastrointestinal Disorders https://ClinicalTrials.gov/show/NCT03644602 Completed Federico II University 2016-12-31
NCT03638544 Reduced Content of Gluten Diet on Patients With Irritable Bowel Syndrome (Pro.Ali.Fun.) https://ClinicalTrials.gov/show/NCT03638544 Completed University of Bari 2016-12-31
NCT03613545 Fecal Microbiota Transplantation for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT03613545 Recruiting Guangzhou First People’s Hospital 2028-12-31
NCT03596905 Efficacy and Safety of Plecanatide in Children 6 to <18 Years of Age With Irritable Bowel Syndrome With Constipation (IBS-C) https://ClinicalTrials.gov/show/NCT03596905 Recruiting Bausch Health Americas, Inc. 2020-12-31
NCT03586622 One Year Home Monitoring and Treatment of IBS Patients https://ClinicalTrials.gov/show/NCT03586622 Recruiting Nordsjaellands Hospital 2020-07-16
NCT03568513 Effect of Curcumin on Gut Microbiota in IBS https://ClinicalTrials.gov/show/NCT03568513 Recruiting Medical College of Wisconsin 2022-03-31
NCT03561519 FMT in the Treatment of IBS https://ClinicalTrials.gov/show/NCT03561519 Completed Joint Authority for Päijät-Häme Social and Health Care 2018-07-01
NCT03550742 Effect of HMOs as Nutritional Support for Normal Bowel Movements in IBS Patients https://ClinicalTrials.gov/show/NCT03550742 Completed Glycom A/S 2019-03-20
NCT03492333 Gluten Free Diet in IBS Patients Stratified According to Their Antigliadin Status https://ClinicalTrials.gov/show/NCT03492333 Completed McMaster University 2016-05-30
NCT03466281 Patient Education for Patients With Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT03466281 Completed Sahlgrenska University Hospital, Sweden 2017-06-30
NCT03462966 Rifaximin on Visceral Hypersensitivity https://ClinicalTrials.gov/show/NCT03462966 Recruiting Cedars-Sinai Medical Center 2020-07-31
NCT03459482 Endpoint Determination Study Protocol https://ClinicalTrials.gov/show/NCT03459482 Recruiting Biomerica 2020-12-31
NCT03457324 Efficacy and Safety of Chinese Medicine JCM-16021 for Diarrhea-predominant Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT03457324 Recruiting Hong Kong Baptist University 2020-06-30
NCT03454386 SMART Program in Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT03454386 Completed University of California, Los Angeles 2019-11-07
NCT03441581 3030-401-002 ELX BAM Study https://ClinicalTrials.gov/show/NCT03441581 Completed Allergan 2020-04-29
NCT03440255 Transcutaneous Vagus Nerve Stimulation in Private Healthcare Center https://ClinicalTrials.gov/show/NCT03440255 Completed Kinesis Health Associates 2017-07-31
NCT03432078 Individual vs. Group Hypnotherapy in Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT03432078 Active, not recruiting Sahlgrenska University Hospital, Sweden 2019-12-31
NCT03423069 Low FODMAPs Diet vs. Specific Dietary Advice in Patients With IBS Diarrheal Variant https://ClinicalTrials.gov/show/NCT03423069 Recruiting Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 2019-07-30
NCT01268709 Effect of Doxepin and Nortriptyline on Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01268709 Completed Qom University of Medical Sciences NA
NCT01253408 Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT01253408 Completed Mayo Clinic 2011-12-31
NCT01252550 Effects of Activia in IBS https://ClinicalTrials.gov/show/NCT01252550 Completed Sahlgrenska University Hospital, Sweden 2014-05-31
NCT01248013 Irritable Bowel Syndrome Hypnotherapy https://ClinicalTrials.gov/show/NCT01248013 Completed Mind-Body Digestive Center 2009-12-31
NCT01225237 A Study to Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male Patients https://ClinicalTrials.gov/show/NCT01225237 Completed Astellas Pharma Inc 2011-08-31
NCT01205100 Treatment of Abdominal Distension by Biofeedback - a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT01205100 Completed Hospital Universitari Vall d’Hebron Research Institute 2016-01-31
NCT01192672 Use of Expressive Writing in Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT01192672 Completed Boston University 2010-09-30
NCT01178593 Group Hypnosis for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01178593 Completed Medical University of Vienna 2010-09-30
NCT01177410 Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea https://ClinicalTrials.gov/show/NCT01177410 Completed Bausch Health Americas, Inc. 2011-08-31
NCT01176227 Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT01176227 Completed The Canadian College of Naturopathic Medicine 2011-02-28
NCT01171053 Internet-delivered CBT for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01171053 Completed Karolinska Institutet 2010-06-30
NCT01166789 Lubiprostone Effects on Visceral Pain Sensitivity https://ClinicalTrials.gov/show/NCT01166789 Completed University of North Carolina, Chapel Hill 2010-08-31
NCT01162863 Effects of Lubiprostone on Gastrointestinal Transit & pH in Irritable Bowel Syndrome (IBS) With Constipation https://ClinicalTrials.gov/show/NCT01162863 Completed University of Michigan 2012-12-31
NCT01153295 “Functional Bowel Disorder. Investigation in General Practice” https://ClinicalTrials.gov/show/NCT01153295 Completed University of Southern Denmark 2011-06-30
NCT01151657 Probiotics for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01151657 Completed University of Southern Denmark 2011-06-30
NCT01149200 Proof-of-Principle Study of TC-6499 in the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT01149200 Completed Targacept Inc. 2010-10-31
NCT01144832 Irritable Bowel Syndrome (IBS) Treatment With H1-receptor Antagonists https://ClinicalTrials.gov/show/NCT01144832 Completed KU Leuven 2012-05-31
NCT01139736 Manipulation of Visceral Hypersensitivity With Probiotic Bacteria in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01139736 Completed Chinese University of Hong Kong 2011-03-31
NCT01130272 Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea https://ClinicalTrials.gov/show/NCT01130272 Completed Furiex Pharmaceuticals, Inc 2011-07-14
NCT01127828 Effects of Cultura Yoghurt in Irritable Bowel Syndrome (IBS) Patients on Intestinal and Immunological Changes https://ClinicalTrials.gov/show/NCT01127828 Completed Good Food Practice, Sweden 2006-05-31
NCT01118988 Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents https://ClinicalTrials.gov/show/NCT01118988 Completed University of California, Los Angeles 2011-06-30
NCT01107977 Iyengar Yoga for Young People With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01107977 Completed University of California, Los Angeles 2013-12-31
NCT01100684 Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) https://ClinicalTrials.gov/show/NCT01100684 Completed Tioga Pharmaceuticals 2013-06-30
NCT01095042 Cognition and Emotion in the SII and IBD https://ClinicalTrials.gov/show/NCT01095042 Completed University Hospital, Grenoble 2013-05-31
NCT01094041 Gluten Intolerance in Patients With Diarrhea Predominant Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01094041 Completed Mayo Clinic 2012-01-31
NCT01088971 Effect of Duolac 7S Administration on Improving Symptom in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01088971 Completed Cell Biotech Co., Ltd. 2011-07-31
NCT01085643 Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS) https://ClinicalTrials.gov/show/NCT01085643 Completed Cedars-Sinai Medical Center 2010-12-31
NCT01056107 Effects of ROSE-010 on GI Transit in Constipation Predominant Irritable Bowel Syndrome (C-IBS) Patients https://ClinicalTrials.gov/show/NCT01056107 Completed Mayo Clinic 2011-12-31
NCT01051973 Cognitive Behavior Therapy (CBT) Compared to Stress Management for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01051973 Completed Karolinska Institutet 2010-12-31
NCT01050465 MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use https://ClinicalTrials.gov/show/NCT01050465 Completed University of Missouri-Columbia 2010-10-31
NCT01047800 Functional Gastrointestinal Disorder Screening Program - A Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT01047800 Completed Chinese University of Hong Kong 2015-05-31
NCT01027260 Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syndrome With Predominant Constipation https://ClinicalTrials.gov/show/NCT01027260 Completed Abbott 2010-08-31
NCT01018498 Pilot Study Using a Dietary Intervention for Children With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01018498 Completed Baylor College of Medicine 2011-09-30
NCT01010191 Harnessing Placebo Effects: Non-Deceptive Use of Placebo in Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT01010191 Completed Harvard University Faculty of Medicine 2010-04-30
NCT00977197 A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00977197 Completed Mayo Clinic 2015-06-30
NCT00971711 Safety Study of Probiotics in Adults With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00971711 Completed Baylor College of Medicine 2013-12-31
NCT00961298 An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder https://ClinicalTrials.gov/show/NCT00961298 Completed West Penn Allegheny Health System 2011-12-31
NCT00955994 Effect of Asimadoline, a Member of a New Medication Class, on Acute Attacks of Pain in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00955994 Completed Mayo Clinic 2007-03-31
NCT00948870 Trial of Chinese Prescription Shugan Decoction on Irritable Bowel Syndrome(Diarrhea Type) https://ClinicalTrials.gov/show/NCT00948870 Completed Shanghai University of Traditional Chinese Medicine 2011-07-31
NCT00948818 Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation https://ClinicalTrials.gov/show/NCT00948818 Completed Forest Laboratories 2010-07-31
NCT00945334 Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00945334 Completed Cedars-Sinai Medical Center 2013-06-30
NCT00938717 Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) https://ClinicalTrials.gov/show/NCT00938717 Completed Ironwood Pharmaceuticals, Inc. 2010-09-30
NCT00934973 Management of Irritable Bowel Syndrome in Primary Care (MIBS Trial) https://ClinicalTrials.gov/show/NCT00934973 Completed University of Southampton 2011-09-30
NCT00934479 Intestinal Microecology in Chronic Constipation https://ClinicalTrials.gov/show/NCT00934479 Completed Mayo Clinic 2012-02-29
NCT00931294 Saliva Testosterone Increases in Irritable Bowel Syndrome (IBS) Patients Beginning Choir Singing https://ClinicalTrials.gov/show/NCT00931294 Completed Stockholm University 2007-05-31
NCT00919672 Treatment of Irritable Bowel Syndrome (IBS) With Sacral Nerve Stimulation https://ClinicalTrials.gov/show/NCT00919672 Completed University of Aarhus 2012-06-30
NCT00918411 A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00918411 Completed Astellas Pharma Inc 2009-12-31
NCT00912301 Cheno Effect on Transit in Health and IBS-C https://ClinicalTrials.gov/show/NCT00912301 Completed Mayo Clinic 2009-11-30
NCT00911612 Does Welchol (Colesevelam Hydrochloride) Improve Colonic Transit in Diarrhea-predominant Irritable Bowel Syndrome (D-IBS)? https://ClinicalTrials.gov/show/NCT00911612 Completed Mayo Clinic 2009-05-31
NCT00907790 Nursing Management of Irritable Bowel Syndrome (IBS) 2008 https://ClinicalTrials.gov/show/NCT00907790 Completed University of Washington 2012-12-31
NCT00900965 Effect of Electroacupuncture in Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00900965 Completed Chinese University of Hong Kong 2008-12-31
NCT00880594 Irritable Bowel Syndrome (IBS) Functional Magnetic Resonance Imaging (fMRI) With Desipramine https://ClinicalTrials.gov/show/NCT00880594 Active, not recruiting Washington University School of Medicine 2020-05-31
NCT00880256 Mindfulness-Based Stress Reduction for Bowel Symptoms: Collection of Pilot Survey Data https://ClinicalTrials.gov/show/NCT00880256 Completed Seattle Institute for Biomedical and Clinical Research 2010-10-31
NCT00844961 Effectiveness of Internet Delivered Cognitive Behavior Therapy (CBT) for Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT00844961 Completed Karolinska Institutet 2011-02-28
NCT03653689 Identification of IBS Metabotypes Based on Physiological Responses to Food https://ClinicalTrials.gov/show/NCT03653689 Completed Uppsala University 2019-06-14
NCT01722318 The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) https://ClinicalTrials.gov/show/NCT01722318 Completed Bausch Health Americas, Inc. 2014-04-30
NCT00829218 Clinical Trial Examining Effects of Monosodium Glutamate (MSG) on Irritable Bowel Syndrome (IBS) and Fibromyalgia (FM) https://ClinicalTrials.gov/show/NCT00829218 Completed Oregon Health and Science University 2009-11-30
NCT04166058 Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C https://ClinicalTrials.gov/show/NCT04166058 Enrolling by invitation Allergan 2023-02-28
NCT00813098 Study of LX1031 in Subjects With Non-Constipating Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00813098 Completed Lexicon Pharmaceuticals 2009-07-31
NCT04296552 Brain-Gut-Microbiota Interaction in IBS https://ClinicalTrials.gov/show/NCT04296552 Recruiting Haukeland University Hospital 2021-12-31
NCT00806104 Fructo-oligosaccharides and Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00806104 Completed Beghin-Meiji 2010-07-31
NCT02550704 Association Between High Faecal Calprotectin, Increased Intestinal Permeability and Visceral Hypersensitivity in IBS-D Patients https://ClinicalTrials.gov/show/NCT02550704 Recruiting University Hospital, Rouen 2020-10-31
NCT03573908 A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) https://ClinicalTrials.gov/show/NCT03573908 Completed Ironwood Pharmaceuticals, Inc. 2019-03-13
NCT03225261 The Effect of Citrus Extract on Gastrointestinal Health https://ClinicalTrials.gov/show/NCT03225261 Recruiting Maastricht University Medical Center 2020-12-31
NCT03252743 ICBT for Pain-predominant FGIDs in Children and Adolescents: an Implementation Study. https://ClinicalTrials.gov/show/NCT03252743 Completed Karolinska Institutet 2018-06-17
NCT02721836 Yoga for Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02721836 Completed Universität Duisburg-Essen 2016-12-31
NCT01940848 Efficacy/Safety Study to Confirm Iberogast’s Efficacy in Patients With Irritable Bowel Syndrome Diagnosed on ROME III Criteria Compared to Placebo https://ClinicalTrials.gov/show/NCT01940848 Completed Bayer 2017-10-25
NCT02579902 Effect of Vitamin D3 Supplementation in Treatment of Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02579902 Completed Ahvaz Jundishapur University of Medical Sciences 2015-08-31
NCT02495623 A Study of the Effect of SYN-010 on Subjects With IBS-C https://ClinicalTrials.gov/show/NCT02495623 Completed Synthetic Biologics Inc. 2015-10-31
NCT02186743 Irritable Bowel Syndrome and Food Sensitivity https://ClinicalTrials.gov/show/NCT02186743 Completed Yale University 2016-01-31
NCT02154867 Fecal Microbial Transplantation in Treatment of Irritable Bowel Syndrome; a Double Blinded Placebo Controlled Trial. https://ClinicalTrials.gov/show/NCT02154867 Completed University Hospital of North Norway 2016-10-31
NCT01829932 The Effect of Prebiotics on the Microbiome in Irritable Bowel Syndrome Patients: The Diet and Microbiome Study https://ClinicalTrials.gov/show/NCT01829932 Completed Queen’s University 2014-12-31
NCT04129619 A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D) https://ClinicalTrials.gov/show/NCT04129619 Recruiting OrphoMed, Inc. 2021-10-31
NCT00788658 Cognitive Behaviour Therapy for Patients With IBS https://ClinicalTrials.gov/show/NCT00788658 Completed Rabin Medical Center 2010-12-31
NCT00786123 Exploring the Mechanism of a Probiotic Combination VSL#3 in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00786123 Completed National University Hospital, Singapore 2009-12-31
NCT00779493 Curcumin (Tumeric) in the Treatment of Irritable Bowel Syndrome: A Randomized-Controlled Trial https://ClinicalTrials.gov/show/NCT00779493 Completed Kaiser Permanente 2009-06-30
NCT00774007 A Randomized Controlled Pilot Trial of Mesalazine in Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00774007 Completed SOFAR S.p.A. 2005-11-30
NCT00765999 An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation https://ClinicalTrials.gov/show/NCT00765999 Completed Forest Laboratories 2012-01-31
NCT00761007 Ibodutant for Relief of Irritable Bowel Syndrome (IRIS) https://ClinicalTrials.gov/show/NCT00761007 Completed Menarini Group 2009-02-28
NCT00745004 Ondansetron for the Treatment of IBS With Diarrhoea (IBS-D) https://ClinicalTrials.gov/show/NCT00745004 Completed University of Nottingham 2011-07-31
NCT00738920 Self Administered Cognitive Behavior Therapy for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00738920 Completed State University of New York at Buffalo 2016-12-31
NCT00731679 Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT00731679 Completed Bausch Health Americas, Inc. 2009-08-31
NCT00731003 The Effect of Serotonergic Modulation on Intestinal Permeability and Visceral Hypersensitivity in Healthy Individuals and Irritable Bowel Syndrome (IBS) Patients https://ClinicalTrials.gov/show/NCT00731003 Completed Maastricht University Medical Center 2011-05-31
NCT00730171 An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation https://ClinicalTrials.gov/show/NCT00730171 Completed Ironwood Pharmaceuticals, Inc. 2012-03-31
NCT00724126 Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT00724126 Completed Bausch Health Americas, Inc. 2009-08-31
NCT00706758 Structured Patient Education Versus Written Information for Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00706758 Completed Sahlgrenska University Hospital, Sweden 2008-06-30
NCT00702026 The Effect of a Multispecies Probiotic on Hypersensitivity in Irritable Bowel Syndrome (IBS) Patients https://ClinicalTrials.gov/show/NCT00702026 Completed Maastricht University Medical Center 2011-12-31
NCT00699166 Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) https://ClinicalTrials.gov/show/NCT00699166 Completed Novartis 2005-09-30
NCT00693732 Validation of Surrogate Measures in Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT00693732 Completed National University Hospital, Singapore 2012-01-31
NCT00680836 Gulf War Digestive Health Study https://ClinicalTrials.gov/show/NCT00680836 Completed VA Office of Research and Development 2008-10-31
NCT00680693 Mindfulness vs. Support Groups for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00680693 Completed University of North Carolina, Chapel Hill 2010-08-31
NCT00676975 The Efficacy of Tradition Chinese Medicine in Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00676975 Completed Chinese University of Hong Kong 2010-12-30
NCT02082457 Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation https://ClinicalTrials.gov/show/NCT02082457 Completed SK Chemicals Co., Ltd. 2014-12-31
NCT00634608 Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow https://ClinicalTrials.gov/show/NCT00634608 Completed University of Missouri-Columbia 2009-03-31
NCT00626288 Mesalazine Therapy in Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00626288 Completed SOFAR S.p.A. 2012-03-31
NCT00616200 Effects of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT00616200 Completed University of North Carolina, Chapel Hill 2010-05-31
NCT00610909 Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT00610909 Completed Duke University 2002-12-31
NCT00589771 Saccharomyces Boulardii in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00589771 Completed Aga Khan University 2011-12-31
NCT00587860 A Placebo-Controlled Trial of St. John’s Wort for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00587860 Completed Mayo Clinic 2008-01-31
NCT00584571 Randomized Controlled Trial of Treating Rectal Hypersensitivity - Comparing Escitalopram With Sensory Adaptation Training https://ClinicalTrials.gov/show/NCT00584571 Active, not recruiting Augusta University 2015-12-31
NCT00584298 Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide https://ClinicalTrials.gov/show/NCT00584298 Completed Novartis 2009-04-30
NCT00583128 Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00583128 Completed Ocera Therapeutics 2010-05-31
NCT00561535 Effect of a Probiotic, Lactobacillus FARCIMINIS, in Diarrhea Predominant IBS Patients https://ClinicalTrials.gov/show/NCT00561535 Completed Assistance Publique - Hôpitaux de Paris 2010-05-31
NCT00555191 Fructose Malabsorption in Northern Norway https://ClinicalTrials.gov/show/NCT00555191 Completed University Hospital of North Norway 2016-05-31
NCT00554320 Effect of Repetitive Transcranial Direct Current Stimulation (tDCS) on Chronic Pelvic Pain https://ClinicalTrials.gov/show/NCT00554320 Completed Summa Health System 2009-06-30
NCT00552565 Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) https://ClinicalTrials.gov/show/NCT00552565 Completed AGI Therapeutics, Inc. 2009-06-30
NCT00542295 Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00542295 Completed Laboratoires Mayoly Spindler 2008-07-31
NCT00526903 Recurrent Abdominal Pain in Children https://ClinicalTrials.gov/show/NCT00526903 Completed Baylor College of Medicine 2014-03-31
NCT00486876 A Study of 3 Doses of Dextofisopam in Females With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00486876 Completed Pharmos 2009-09-30
NCT00477165 Citalopram in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00477165 Completed Stanford University 2009-06-30
NCT00468013 A Computer-Based Intervention for Medically Unexplained Physical Symptoms https://ClinicalTrials.gov/show/NCT00468013 Completed Rutgers, The State University of New Jersey 2010-03-31
NCT00461526 Diarrhea Predominant Irritable Bowel Syndrome in Females https://ClinicalTrials.gov/show/NCT00461526 Completed Bausch Health Americas, Inc. 2007-12-31
NCT00460811 Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) https://ClinicalTrials.gov/show/NCT00460811 Completed Ironwood Pharmaceuticals, Inc. 2008-02-29
NCT00454688 Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00454688 Completed Tioga Pharmaceuticals 2007-11-30
NCT00421707 Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00421707 Completed GlaxoSmithKline 2008-06-25
NCT00401479 A Study To Investigate The Effect Of Solabegron (GW427353) On Gastrointestinal Transit In Healthy Volunteers https://ClinicalTrials.gov/show/NCT00401479 Completed GlaxoSmithKline NA
NCT00401258 An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00401258 Completed Mclean Hospital 2008-02-29
NCT00399542 Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation https://ClinicalTrials.gov/show/NCT00399542 Completed Mallinckrodt 2006-07-31
NCT00399438 A Study of BMS-562086 in Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00399438 Completed Bristol-Myers Squibb 2007-10-31
NCT00394186 A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT00394186 Completed GlaxoSmithKline NA
NCT00394173 Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) https://ClinicalTrials.gov/show/NCT00394173 Completed Novartis 2007-10-31
NCT00385099 Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00385099 Completed GlaxoSmithKline 2007-10-15
NCT00380250 Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation https://ClinicalTrials.gov/show/NCT00380250 Completed Mallinckrodt NA
NCT00376896 Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers https://ClinicalTrials.gov/show/NCT00376896 Completed GlaxoSmithKline 2008-10-31
NCT00374673 Efficacy of Transcranial Magnetic Stimulation (TMS) in Chronic Idiopathic Pain Disorders https://ClinicalTrials.gov/show/NCT00374673 Completed Hospital Ambroise Paré Paris 2012-03-31
NCT00370032 Study to Assess the Effect Of Alosetron On Mucosal Blood Flow https://ClinicalTrials.gov/show/NCT00370032 Completed GlaxoSmithKline 2007-12-31
NCT00368771 A Six-month Study to Compare Outcome Differences and Visceral Response … Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00368771 Completed University of California, Los Angeles 2009-05-31
NCT00355810 Probiotics for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00355810 Completed Norwegian University of Science and Technology 2006-04-30
NCT00331994 EFESO - EFficacy Enterogermina Small Intestinal Bacterial Overgrowth https://ClinicalTrials.gov/show/NCT00331994 Completed Sanofi 2008-07-31
NCT00305968 Evaluation of Patient Education in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00305968 Completed Sorlandet Hospital HF 2008-01-31
NCT00269412 Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00269412 Completed Bausch Health Americas, Inc. 2007-08-31
NCT00268879 Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT00268879 Completed Alizyme 2008-01-31
NCT00259155 Rifaximin for the Treatment of Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00259155 Completed Cedars-Sinai Medical Center 2007-01-31
NCT00258193 Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS https://ClinicalTrials.gov/show/NCT00258193 Completed Ironwood Pharmaceuticals, Inc. NA
NCT00230581 8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS https://ClinicalTrials.gov/show/NCT00230581 Completed Dynogen Pharmaceuticals NA
NCT00220090 DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in Constipation-Predominant Irritable Bowel Syndrome (C-IBS) https://ClinicalTrials.gov/show/NCT00220090 Completed Rottapharm 2006-09-30
NCT00215566 A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c https://ClinicalTrials.gov/show/NCT00215566 Completed Dynogen Pharmaceuticals NA
NCT00194922 Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT00194922 Completed Weill Medical College of Cornell University 2006-11-30
NCT00189813 A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS) https://ClinicalTrials.gov/show/NCT00189813 Completed Astellas Pharma Inc 2005-12-31
NCT00189696 Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS) https://ClinicalTrials.gov/show/NCT00189696 Completed Astellas Pharma Inc NA
NCT00189033 Dietary Interventions in Irritable Bowel Syndrome: Soluble, Insoluble or no Fibre? https://ClinicalTrials.gov/show/NCT00189033 Completed UMC Utrecht NA
NCT00167635 Nursing Management of Irritable Bowel Syndrome:Improving Outcomes https://ClinicalTrials.gov/show/NCT00167635 Completed University of Washington 2008-02-29
NCT00142987 Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS https://ClinicalTrials.gov/show/NCT00142987 Completed Novartis NA
NCT00139672 A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS. https://ClinicalTrials.gov/show/NCT00139672 Completed Pfizer 2005-02-28
NCT00135031 Efficacy of an Encapsulated Probiotic Bifidobacterium Infantis 35624 in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00135031 Completed Procter and Gamble 2004-09-30
NCT00130741 Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT00130741 Completed Hadassah Medical Organization NA
NCT00108446 Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00108446 Completed VA Office of Research and Development NA
NCT00101985 Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT00101985 Completed GlaxoSmithKline 2005-07-31
NCT00101725 A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00101725 Completed Bausch Health Americas, Inc. 2005-11-30
NCT00100425 Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00100425 Completed VA Office of Research and Development NA
NCT00093327 Acupuncture for Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT00093327 Completed National Center for Complementary and Integrative Health (NCCIH) NA
NCT00006157 Treatment of Functional Bowel Disorders https://ClinicalTrials.gov/show/NCT00006157 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NA
NCT00067561 Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy https://ClinicalTrials.gov/show/NCT00067561 Completed GlaxoSmithKline 2005-01-31
NCT00067457 Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy https://ClinicalTrials.gov/show/NCT00067457 Completed GlaxoSmithKline 2005-12-31
NCT00065754 Brain Imaging and Pain in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00065754 Completed University of Florida 2007-12-31
NCT00065403 Acupuncture for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00065403 Completed National Center for Complementary and Integrative Health (NCCIH) NA
NCT00796354 Constipation Associated With Irritable Bowel Syndrome (IBS-C) https://ClinicalTrials.gov/show/NCT00796354 Completed Norgine 2010-02-28

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03370614 Pilot Study of the Physiological Effects of an Integrative Medicine Approach in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT03370614 Enrolling by invitation Thomas Jefferson University 2021-06-30
NCT03366389 Serum Levels of Apelin, Chemerin and Adiponectin Adipokines in Irritable Bowel Syndrome and Healthy Subjects https://ClinicalTrials.gov/show/NCT03366389 Completed Lorestan University of Medical Sciences 2017-09-16
NCT03824821 Assessing Associations Between IBS Symptoms, Nutrition and QoL in IBS Patients Using a Questionnaire https://ClinicalTrials.gov/show/NCT03824821 Completed Wageningen University 2018-05-31
NCT03336034 Assessment of Responsiveness to Treatment by Experience Sampling Method https://ClinicalTrials.gov/show/NCT03336034 Recruiting Maastricht University Medical Center 2021-01-31
NCT03266068 Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders https://ClinicalTrials.gov/show/NCT03266068 Active, not recruiting Mayo Clinic 2020-12-31
NCT03223077 Mucosal and Microbiota Changes During Acute Campylobacteriosis https://ClinicalTrials.gov/show/NCT03223077 Recruiting Mayo Clinic 2022-06-30
NCT03143517 Fecal Calprotectin Collection Protocol https://ClinicalTrials.gov/show/NCT03143517 Completed DiaSorin Inc. 2018-08-23
NCT03082287 ALPCO Calprotectin ELISA - Measurement of Calprotectin Levels in Human Stool https://ClinicalTrials.gov/show/NCT03082287 Completed American Laboratory Products Company 2019-10-25
NCT03022994 Duodenal and Rectal Histology in Non-celiac Wheat Sensitivity and Irritable Bowel Syndrome Patients https://ClinicalTrials.gov/show/NCT03022994 Completed University of Palermo 2017-01-31
NCT03002584 International Psychometric Validation Study of the Intestinal Gas Questionnaire (IGQ) https://ClinicalTrials.gov/show/NCT03002584 Completed University Paris 7 - Denis Diderot 2018-04-30
NCT02981888 Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02981888 Recruiting Indiana University 2021-07-31
NCT02955316 Irritable Bowel Syndrome Survey in Gastroenterological Adult Outpatients in China https://ClinicalTrials.gov/show/NCT02955316 Completed AstraZeneca 2017-09-30
NCT02813616 Factors Affecting Dissatisfaction to Treatments in Patients With Chronic Constipation and IBS With Constipation https://ClinicalTrials.gov/show/NCT02813616 Completed Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico 2018-07-31
NCT02693730 Phenotyping IBS: Perceptions and Modulations of Visceral Sensations https://ClinicalTrials.gov/show/NCT02693730 Active, not recruiting University of California, Los Angeles 2020-08-31
NCT02661425 Retrospective Study of IBS-D Patients Previously Receiving SBI https://ClinicalTrials.gov/show/NCT02661425 Completed Entera Health, Inc 2016-09-30
NCT02651532 Confocal Endomicroscopy Utility (p-CLE) in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02651532 Completed Instituto Ecuatoriano de Enfermedades Digestivas 2017-03-31
NCT02612649 Special Drug Use Surveillance of Irribow in Female Patients https://ClinicalTrials.gov/show/NCT02612649 Completed Astellas Pharma Inc 2018-03-31
NCT02516683 The Long Term Clinical Course of Postinfectious Irritable Bowel Syndrome After Shigellosis; A 10 Year Follow up Study https://ClinicalTrials.gov/show/NCT02516683 Completed Yonsei University 2011-12-31
NCT02351635 BÜHLMANN fCAL™ ELISA - Aid in Differentiation of IBD From IBS https://ClinicalTrials.gov/show/NCT02351635 Completed Bühlmann Laboratories AG 2018-03-31
NCT02249169 Developing Novel Microbiota-Targeted Therapies for Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02249169 Active, not recruiting Mayo Clinic 2020-12-31
NCT02246647 Biomarkers for Intestinal Permeability in Patients With Constipation https://ClinicalTrials.gov/show/NCT02246647 Completed Mayo Clinic 2016-12-08
NCT02179905 Brain Imaging, Heart Rate Variability and Serum Fatty Acid in Subjects With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02179905 Completed Shin Kong Wu Ho-Su Memorial Hospital 2013-09-30
NCT02113111 Effects of Fasting on Self Efficacy https://ClinicalTrials.gov/show/NCT02113111 Completed Universität Duisburg-Essen 2015-07-31
NCT02003807 Incidence and Predictive Factor of Irritable Bowel Syndrome After Acute Diverticulitis in Korea https://ClinicalTrials.gov/show/NCT02003807 Completed Yonsei University 2013-09-30
NCT01854060 Predictive Factors for a Clinical Diagnosis of Irritable Bowel Syndrome in a Large Cohort of Young Adults. https://ClinicalTrials.gov/show/NCT01854060 Completed Medical Corps, Israel Defense Force 2013-05-31
NCT01718925 25-hydroxyvitamin D and Fatigue: The VITALITY Study https://ClinicalTrials.gov/show/NCT01718925 Completed Ostfold Hospital Trust 2014-11-30
NCT01705171 Is the Expression of the GLUT5 Specific Fructose Transport Protein Abnormal in Patients With Fructose Intolerance? https://ClinicalTrials.gov/show/NCT01705171 Completed Brain-Gut Research Group 2013-05-31
NCT01697397 Gastrointestinal Myoelectric Activity Protocol, the G-Tech EEnG Protocol https://ClinicalTrials.gov/show/NCT01697397 Completed G-Tech Corporation 2015-06-30
NCT01678781 Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide https://ClinicalTrials.gov/show/NCT01678781 Completed Abbott 2013-08-31
NCT01674088 Sucrose Breath Test to Determine Intestinal Permeability in IBS https://ClinicalTrials.gov/show/NCT01674088 Completed Metabolic Solutions Inc. 2012-12-31
NCT01618292 Cohort Study of Bowel Function Following Robotic-assisted Laparoscopic Sacrocolpopexy https://ClinicalTrials.gov/show/NCT01618292 Completed Atlantic Health System 2012-08-31
NCT01574209 Gut Peptides and Intestinal Permeability in Celiac Disease and Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01574209 Completed Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 2012-09-30
NCT01558284 The Effect of Neu-P11 on Symptoms in Patients With D-IBS https://ClinicalTrials.gov/show/NCT01558284 Completed Ludwig-Maximilians - University of Munich 2014-01-31
NCT01534507 Small and Large Bowel Transit Tests Using MRI (Study 1) https://ClinicalTrials.gov/show/NCT01534507 Completed University of Nottingham 2014-08-31
NCT01517516 Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest. https://ClinicalTrials.gov/show/NCT01517516 Completed University of California, Los Angeles 2015-07-31
NCT01497847 Post-Infectious Irritable Bowel Syndrome (PI-IBS) https://ClinicalTrials.gov/show/NCT01497847 Completed KU Leuven 2013-02-28
NCT01476995 Prognostic Indicators as Provided by the EPIC ClearView https://ClinicalTrials.gov/show/NCT01476995 Completed Epic Research & Diagnostics, Inc. 2011-06-30
NCT01457378 Gastrointestinal Symptoms in Healthy Subjects and Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT01457378 Completed Danone Research 2011-10-31
NCT01436760 Genetic Contribution of Pain and Inflammation in IBS https://ClinicalTrials.gov/show/NCT01436760 Completed University of Florida 2012-03-31
NCT04324658 Effect and Tolerance of a Probiotic-based Medical Device Administered to Patients With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT04324658 Recruiting Pileje 2020-05-31
NCT04306939 Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study https://ClinicalTrials.gov/show/NCT04306939 Recruiting University of Pittsburgh 2025-12-01
NCT04214470 A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS https://ClinicalTrials.gov/show/NCT04214470 Recruiting ProgenaBiome 2023-03-31
NCT04138225 The Ecological Role of Yeasts in the Human Gut https://ClinicalTrials.gov/show/NCT04138225 Recruiting University of Reading 2020-05-23
NCT04060121 Efficacy of Psychological Therapies in Patients With Functional Bowel Disorders https://ClinicalTrials.gov/show/NCT04060121 Recruiting Indiana University 2020-08-31
NCT04020835 Understanding Abdominal Pain in IBD and IBS https://ClinicalTrials.gov/show/NCT04020835 Recruiting Guy’s and St Thomas’ NHS Foundation Trust 2020-01-31
NCT03983434 Irritable Bowel Syndrome and Control Volunteers: Diet Challenge https://ClinicalTrials.gov/show/NCT03983434 Recruiting Indiana University 2021-06-30
NCT03720314 Microbiota Profiling in IBS https://ClinicalTrials.gov/show/NCT03720314 Completed Wageningen University 2018-12-15
NCT03620994 The Predictive Value of Alarm Symptoms in Patients With Irritable Bowel Syndrome Based on Rome IV https://ClinicalTrials.gov/show/NCT03620994 Recruiting Second Affiliated Hospital of Xi’an Jiaotong University 2019-03-01
NCT03549143 Multicenter Observational Prospective Study to Describe Irritable Bowel Syndrome in the Russian Federation https://ClinicalTrials.gov/show/NCT03549143 Completed Abbott 2019-04-19
NCT03471728 Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases) https://ClinicalTrials.gov/show/NCT03471728 Recruiting Astellas Pharma Inc 2021-12-31
NCT01257477 LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) https://ClinicalTrials.gov/show/NCT01257477 Completed Prometheus Laboratories 2013-03-31
NCT01204515 Abdominal Symptom Phenotype Study in Children https://ClinicalTrials.gov/show/NCT01204515 Completed Baylor College of Medicine 2012-08-31
NCT01166802 Development of a Questionnaire to Measure Hypervigilance for Visceral Pain https://ClinicalTrials.gov/show/NCT01166802 Completed University of North Carolina, Chapel Hill 2010-06-30
NCT01099787 Pediatric Alliance for International Neurogastrointestinal Functional Research https://ClinicalTrials.gov/show/NCT01099787 Completed Nationwide Children’s Hospital 2017-06-30
NCT01099111 Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders https://ClinicalTrials.gov/show/NCT01099111 Completed King Fahad Medical City 2012-01-31
NCT01098292 Observational Study of Control Participants for the MAPP Research Network https://ClinicalTrials.gov/show/NCT01098292 Completed University of Pennsylvania 2013-06-30
NCT01072916 Serine Proteases in Gastrointestinal Function and Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT01072916 Completed University of North Carolina, Chapel Hill 2015-12-31
NCT01072903 The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS) https://ClinicalTrials.gov/show/NCT01072903 Completed University of North Carolina, Chapel Hill 2012-07-31
NCT00920400 Diagnostic Value of Fecal Calprotectin in Disorders of the Upper Gastrointestinal Tract https://ClinicalTrials.gov/show/NCT00920400 Completed University Hospital, Basel, Switzerland 2009-09-30
NCT00904696 Tolerability and Effectiveness of Progut in Treatment of Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00904696 Completed National University Hospital, Singapore 2009-09-30
NCT00846794 AcuGraph and Digestive Symptoms https://ClinicalTrials.gov/show/NCT00846794 Completed Logan College of Chiropractic 2010-03-31
NCT03342287 Cognitive and Psychiatric Effects of Linaclotide on Patients With Constipation https://ClinicalTrials.gov/show/NCT03342287 Active, not recruiting McMaster University 2020-12-31
NCT02880722 Experience Sampling Method for Symptom Assessment in Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT02880722 Recruiting Maastricht University Medical Center 2021-01-31
NCT04182048 Remote Study of an Electronic Means to Characterize Bowel Movements in Adult Populations https://ClinicalTrials.gov/show/NCT04182048 Active, not recruiting HealthMode Inc. 2021-12-31
NCT00810329 Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome https://ClinicalTrials.gov/show/NCT00810329 Completed Georgetown University 2011-04-30
NCT00775060 Maastricht IBS Cohort https://ClinicalTrials.gov/show/NCT00775060 Recruiting Maastricht University Medical Center 2024-09-30
NCT00728026 Autonomic Profiles in Pediatric Patients With Cyclic Vomiting Syndrome (CVS), Irritable Bowel Syndrome (IBS),Postural Orthostatic Tachycardia Syndrome (POTS), Functional Abdominal Pain (FAP) or Chronic Nausea https://ClinicalTrials.gov/show/NCT00728026 Completed Medical College of Wisconsin 2016-09-16
NCT00677976 Use of Functional Magnetic Resonance Imaging (fMRI) to Study Brain Activation in Children With Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00677976 Completed Medical College of Wisconsin 2013-06-30
NCT00659763 Diagnostic Strategies in Patients Suspected of Irritable Bowel Syndrome https://ClinicalTrials.gov/show/NCT00659763 Completed Zealand University Hospital 2010-11-30
NCT00235326 Chronic Gastrointestinal Sequelae of an Acute Outbreak of Bacterial Gastroenteritis in Walkerton Ontario https://ClinicalTrials.gov/show/NCT00235326 Completed McMaster University 2008-08-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03178877 The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors https://ClinicalTrials.gov/show/NCT03178877 Completed Indonesia University 2016-12-31
NCT03131414 The IMAGINE-SPOR CIHR Chronic Disease Network https://ClinicalTrials.gov/show/NCT03131414 Recruiting Hamilton Health Sciences Corporation 2022-06-01
NCT02822677 A Cross-sectional Study on IBS Subtypes, Chinese Medicine Pattern and Host-gut Microbiota Metabolic Interactions https://ClinicalTrials.gov/show/NCT02822677 Completed Hong Kong Baptist University 2017-01-16
NCT02197780 Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD https://ClinicalTrials.gov/show/NCT02197780 Completed University Medical Center Groningen 2017-03-31
NCT03920202 Long - Term Low Anterior Resection Syndrome https://ClinicalTrials.gov/show/NCT03920202 Completed National Cancer Institute, Lithuania 2014-01-01
NCT03778918 The Comparison Between the Biomarkers in Inflammatory Bowel Disease Patients and General Control Group https://ClinicalTrials.gov/show/NCT03778918 Recruiting Seoul St. Mary’s Hospital 2020-06-30